496

Compound name
Pacritinib
Alt Name
SB1518
SB-1518
Compound Image
Pacritinib.png
SMILES
C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2
MW
472.60
Brutto
C28H32N4O3
InChI
InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+
InChI Key
HWXVIOGONBBTBY-ONEGZZNKSA-N
Approval Jurisdiction
2022 FDA
Approved for clinical use
Myelofibrosis
CAS
937272-79-2
PubChem CID
46216796
Action
JAK/IRAK
Approved Drug List
1
Commercial Vendor
CTI BioPharm